Broncus Holding Corp is an investment holding company primarily engaged in the research and development, and the manufacture and commercialisation of medical devices and consumables. The Company’s lung cancer treatment pipeline products primarily include the BroncAblate radiofrequency ablation system, a transbronchial interventional treatment product. The chronic obstructive pulmonary disease (COPD) treatment pipeline products primarily include the InterVapor thermal vapor treatment system and the lung targeted denervation (TLD) radiofrequency ablation energy system. The other lung disease diagnostic and treatment pipeline products primarily include the Mist Fountain disposable nebulizing micro-catheter for endoscope and the BroncTru disposable transbronchoscopic dilatation catheter. The other products primarily include navigation-based flexible surgical robot and the lung image processing software BroncQCT. The Company operates its businesses in the domestic and overseas markets.